• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mucormycosis, conflicts and COVID-19: A deadly recipe for the fragile health system of Afghanistan.

作者信息

Essar Mohammad Yasir, Khan Hiba, Babar Maryam Salma, Hasan Mohammad Mehedi, Rackimuthu Sudhan, Dos Santos Costa Ana Carla, Ahmad Shoaib, Nemat Arash

机构信息

Kabul University of Medical Sciences, Kabul, Afghanistan.

Dubai Medical College, Dubai, United Arab Emirates.

出版信息

Int J Health Plann Manage. 2022 Jan;37(1):543-546. doi: 10.1002/hpm.3292. Epub 2021 Jul 31.

DOI:10.1002/hpm.3292
PMID:34333804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8426834/
Abstract
摘要

相似文献

1
Mucormycosis, conflicts and COVID-19: A deadly recipe for the fragile health system of Afghanistan.毛霉菌病、冲突与新冠疫情：给阿富汗脆弱卫生系统带来的致命组合。
Int J Health Plann Manage. 2022 Jan;37(1):543-546. doi: 10.1002/hpm.3292. Epub 2021 Jul 31.
2
COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.COVID-19 和毛霉菌病综合征：印度崩溃的医疗体系面临的双重健康威胁。
Trop Med Int Health. 2021 Sep;26(9):1016-1018. doi: 10.1111/tmi.13641. Epub 2021 Jun 24.
3
The risk of cutaneous mucormycosis associated with COVID-19: A perspective from Pakistan.COVID-19 相关皮肤毛霉菌病的风险：来自巴基斯坦的观点。
Int J Health Plann Manage. 2022 Mar;37(2):1157-1159. doi: 10.1002/hpm.3311. Epub 2021 Sep 2.
4
Rhino-Orbital-Cerebral Mucormycosis-Another Deadly Complication of COVID-19 Infection.鼻眶脑型毛霉菌病——新型冠状病毒肺炎感染的另一致命并发症
JAMA Ophthalmol. 2022 Jan 1;140(1):73-74. doi: 10.1001/jamaophthalmol.2021.5202.
5
Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.COVID-19 相关非糖尿病患者的鼻眶脑毛霉菌病。
R I Med J (2013). 2021 Oct 1;104(8):19-21.
6
Mucormycosis: An opportunistic pathogen during COVID-19.毛霉菌病：COVID-19 期间的机会性病原体。
Environ Res. 2021 Oct;201:111643. doi: 10.1016/j.envres.2021.111643. Epub 2021 Jul 6.
7
Five probable factors responsible for the COVID-associated mucormycosis outbreak in India.导致印度 COVID 相关毛霉菌病爆发的五个可能因素。
Int J Infect Dis. 2021 Nov;112:278-280. doi: 10.1016/j.ijid.2021.09.057. Epub 2021 Sep 27.
8
Does COVID 19 generate a milieu for propagation of mucormycosis?新冠病毒是否会为毛霉菌病的传播创造环境？
Med Hypotheses. 2021 Jul;152:110613. doi: 10.1016/j.mehy.2021.110613. Epub 2021 May 26.
9
Mucormycosis: time to address this deadly fungal infection.毛霉病：是时候应对这种致命的真菌感染了。
Lancet Microbe. 2021 Aug;2(8):e343-e344. doi: 10.1016/S2666-5247(21)00148-8. Epub 2021 Jun 14.
10
The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance.新型冠状病毒感染患者中毛霉菌病（黑霉病）的影响：一目了然。
Environ Sci Pollut Res Int. 2022 Oct;29(46):69341-69366. doi: 10.1007/s11356-022-22204-8. Epub 2022 Aug 19.

引用本文的文献

1
Infectious disease control: from health security strengthening to health systems improvement at global level.传染病控制：从全球层面加强卫生安全到改善卫生系统。
Glob Health Res Policy. 2023 Sep 5;8(1):38. doi: 10.1186/s41256-023-00319-w.
2
Antifungal Drugs Shortage in India amidst Looming Increase in Invasive Fungal Infections among COVID-19 Patients: An Impending Crisis.印度抗真菌药物短缺，新冠患者侵袭性真菌感染风险渐高：一场迫在眉睫的危机。
Innov Pharm. 2022 Dec 12;13(2). doi: 10.24926/iip.v13i2.4480. eCollection 2022.
3
Hijab or Niqab Interacts with Facemasks Usage at Healthcare Settings in Kabul, Afghanistan: A Multi-Center Observational Study.阿富汗喀布尔医疗机构中 Hijab 或 Niqab 与口罩使用的相互影响：一项多中心观察性研究
Healthcare (Basel). 2022 Oct 5;10(10):1946. doi: 10.3390/healthcare10101946.
4
Emergence of a medley of invasive fungal infections amidst the coronavirus disease 2019 (COVID-19) pandemic in India.在印度2019冠状病毒病（COVID-19）大流行期间，多种侵袭性真菌感染出现。
Antimicrob Steward Healthc Epidemiol. 2021 Nov 2;1(1):e40. doi: 10.1017/ash.2021.198. eCollection 2021.
5
The minimal COVID-19 vaccination coverage and efficacy to compensate for a potential increase of transmission contacts, and increased transmission probability of the emerging strains.最低限度的 COVID-19 疫苗接种覆盖率和效力，以补偿潜在的传播接触增加，以及新兴菌株传播概率的增加。
BMC Public Health. 2022 Jun 27;22(1):1258. doi: 10.1186/s12889-022-13429-w.
6
The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.IL-1 家族细胞因子及其受体在 COVID-19 发病机制中的作用。
Inflamm Res. 2022 Aug;71(7-8):923-947. doi: 10.1007/s00011-022-01596-w. Epub 2022 Jun 25.
7
COVID-19 associated pulmonary aspergillosis (CAPA): An added potential burden on India's pre-existing fungal superinfection.2019冠状病毒病相关肺曲霉病（CAPA）：给印度原有的真菌重叠感染增添了潜在负担。
Clin Epidemiol Glob Health. 2022 Jan-Feb;13:100960. doi: 10.1016/j.cegh.2021.100960. Epub 2022 Jan 4.
8
Tuberculosis in the middle of COVID-19 in Morocco: efforts, challenges and recommendations.摩洛哥新冠疫情期间的结核病：努力、挑战与建议
Trop Med Health. 2021 Dec 20;49(1):98. doi: 10.1186/s41182-021-00388-y.
9
COVID-19 and multiple crises in Afghanistan: an urgent battle.新冠疫情与阿富汗的多重危机：一场紧急战斗。
Confl Health. 2021 Sep 17;15(1):70. doi: 10.1186/s13031-021-00406-0.
10
Dengue and Coronavirus disease (COVID-19) syndemic: Double threat to an overburdened healthcare system in Africa.登革热和冠状病毒病（COVID-19）双重流行：对非洲不堪重负的医疗体系的双重威胁。
Int J Health Plann Manage. 2022 May;37(3):1851-1854. doi: 10.1002/hpm.3334. Epub 2021 Sep 14.

本文引用的文献

1
Challenges of drug supply: How Afghanistan is struggling.药品供应的挑战：阿富汗如何应对困境。
Public Health Pract (Oxf). 2021 May 2;2:100129. doi: 10.1016/j.puhip.2021.100129. eCollection 2021 Nov.
2
Viral infections amidst COVID-19 in Africa: Implications and recommendations.非洲 COVID-19 疫情中的病毒感染：影响和建议。
J Med Virol. 2021 Dec;93(12):6798-6802. doi: 10.1002/jmv.27211. Epub 2021 Jul 22.
3
Dengue, measles, and COVID-19: A threefold challenge to public health security in Pakistan.登革热、麻疹和新冠肺炎：对巴基斯坦公共卫生安全的三重挑战。
Ethics Med Public Health. 2021 Dec;19:100704. doi: 10.1016/j.jemep.2021.100704. Epub 2021 Jul 2.
4
Challenges of COVID-19 vaccination in Afghanistan: A rising concern.阿富汗新冠疫苗接种面临的挑战：日益令人担忧的问题。
Ethics Med Public Health. 2021 Dec;19:100703. doi: 10.1016/j.jemep.2021.100703. Epub 2021 Jul 2.
5
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病：全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
6
Lassa fever and COVID-19 in Africa: A double crisis on the fragile health system.非洲的拉沙热与新冠疫情：对脆弱卫生系统的双重危机
J Med Virol. 2021 Oct;93(10):5707-5709. doi: 10.1002/jmv.27169. Epub 2021 Jul 6.
7
Measles returns to the Democratic Republic of Congo: A new predicament amid the COVID-19 crisis.麻疹在刚果民主共和国卷土重来：新冠疫情危机下的新困境。
J Med Virol. 2021 Oct;93(10):5691-5693. doi: 10.1002/jmv.27137. Epub 2021 Jun 21.
8
COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.COVID-19 和毛霉菌病综合征：印度崩溃的医疗体系面临的双重健康威胁。
Trop Med Int Health. 2021 Sep;26(9):1016-1018. doi: 10.1111/tmi.13641. Epub 2021 Jun 24.
9
Colossal challenges to healthcare workers combating the second wave of coronavirus disease 2019 (COVID-19) in India.印度医护人员在抗击2019年冠状病毒病（COVID-19）第二波疫情时面临的巨大挑战。
Infect Control Hosp Epidemiol. 2022 Sep;43(9):1302-1303. doi: 10.1017/ice.2021.257. Epub 2021 Jun 2.
10
The precariousness of political management of the SARS-CoV-2 pandemic in the search for scientific answers: Calling for prudence in public health emergencies.在寻求科学答案过程中新冠疫情政治管理的不稳定：呼吁在突发公共卫生事件中保持审慎。
Int J Health Plann Manage. 2021 Sep;36(5):1387-1391. doi: 10.1002/hpm.3253. Epub 2021 May 24.